UK studies examining vitiligo burden and vitiligo-related healthcare resource utilization (HCRU) are lacking.
No takes yet. Share an insight, caveat, or question.
Eleftheriadou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: